Table 4 Key ADME parameters of Quinazolinone derivatives.

From: Synthesis, comprehensive in silico studies, and cytotoxicity evaluation of novel quinazolinone derivatives as potential anticancer agents

Molecule

Molecular Weight (g/mol)

TPSA (Ã…Â2)

Log P (iLOGP)

GI absorption

BBB permeability

P-gp substrate

Bioavailability score

2

367.4

60.17

3.3

High

Yes

No

0.55

3

399.44

101.29

2.23

High

No

No

0.55

4

364.42

48.51

3.31

High

Yes

Yes

0.55

5

364.42

48.51

3.31

High

Yes

Yes

0.55

6

364.4

58.89

3.13

High

No

Yes

0.55

7

381.43

77.98

3.11

High

No

No

0.55

8

423.46

81.06

3.15

High

No

No

0.55

9

511.53

89.34

3.45

High

No

No

0.17

10

423.46

78.51

2.93

High

Yes

No

0.55

11

516.61

108.11

3.88

Low

No

No

0.17

12

442.47

130.39

2.2

High

No

No

0.55

13

424.45

107.08

2.89

High

No

No

0.55

14

611.69

82.14

4.94

Low

No

No

0.17

15

653.73

91.37

4.94

Low

No

No

0.17

  1. This table summarizes selected Pharmacokinetic properties predicted using swissadme. Parameters include molecular weight (MW), topological Polar surface area (TPSA), lipophilicity (Log P via iLOGP), Gastrointestinal (GI) absorption, blood-brain barrier (BBB) permeability, P-glycoprotein (P-gp) substrate prediction, and estimated oral bioavailability score.